Jim Cramer Weighs In On Berkshire Hathaway, Range Resources, Zynerba And More

On Monday's “Mad Money,” Jim Cramer said he remains bearish on Range Resources Corp. RRC saying natural gas is the weakest part of the petrol chain.

Cramer says although it's speculative, he is bullish on gene sequencing stock Guardant Health Inc GH.

He remains bullish on Berkshire Hathaway Inc. Class B (NYSE: BRK-B) and has been recommending the stock since the show began.

Seattle Genetics, Inc. SGEN is a buy, says Cramer.

Cramer says to steer clear of Zynerba Pharmaceuticals Inc ZYNE and if you want to play cannabinoids, GW Pharmaceuticals PLC-ADR GWPH is what he would buy.

Related Links:

'Halftime Report' Final Trades From July 16: American Airlines, JetBlue And More

'Fast Money' Traders Talk Retail: Costco, Target And More

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisLong IdeasShort IdeasMarketsTrading IdeasCNBCJim CramerMad Money
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.